Skip to main content
Clinical Trials/NCT06272396
NCT06272396
Recruiting
Not Applicable

Feasibility and Diagnostic Relevance of Recording an ECG Trace With a Connected Watch

University Hospital, Bordeaux1 site in 1 country3,000 target enrollmentMarch 26, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arrhythmias, Cardiac
Sponsor
University Hospital, Bordeaux
Enrollment
3000
Locations
1
Primary Endpoint
Comparison of electrical parameters measured using the 2 ECG methods: P-wave duration
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Over the past few years, various systems have been developed to record ECG traces on an ambulatory basis. The latest connected watch models feature 2-electrode ECG recording. This single (1D) or six derivations (6D) can be used to derive a wealth of information about the heart's rhythm. The information that can be derived from an ECG recording with a derivation goes far beyond̀ simple differentiation between atrial fibrillation and sinus rhythm. In contrast, in various clinical situations, a tracing restricted to an intracardiac defibrillator (ICD) may prove falsely normal, wrongly reassuring a patient and delaying management. The primary objective of the study is to evaluate the sensitivity of ECG-1D or 6D recordings from a connected watch in measuring electrical parameters, compared with a standard ECG-12D, also to obtain a bank of tracings, to create and validate an artificial intelligence algorithm for the automatic analysis of ECG tracings recorded with a connected watch and also to validate the feasibility and sensitivity of recording an ECG tracing with a connected watch in children.

Detailed Description

Single-arm prospective study to evaluate the measurement of electrocardiographic parameters obtained using two non-invasive ECG methods, one 12-lead reference method and the second 1 or 6 leads recorded from a connected watch, in a group of patients with healthy hearts (normal ECG) and 19 pathological groups.

Registry
clinicaltrials.gov
Start Date
March 26, 2024
End Date
March 26, 2028
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients hospitalized or seen in consultation in one of the departments of the Haut Lévêque cardiology hospital,
  • Patient of both sexes, minor (from birth to 18 years) or adult,
  • Free, informed and written consent from the patient or, in the case of minors, from the legal parent (at the latest on the day of inclusion and before any examination required for the research),
  • Subject affiliated to or benefiting from a social security regime.

Exclusion Criteria

  • Person incapable of giving consent,
  • Person subject to a legal protection measure (safeguard of justice, tutorship or curatorship),
  • A person deprived of liberty by judicial or administrative decision.

Outcomes

Primary Outcomes

Comparison of electrical parameters measured using the 2 ECG methods: P-wave duration

Time Frame: 36 months

Mean of P-wave duration

Comparison of electrical parameters measured using the 2 ECG methods: P-wave amplitude

Time Frame: 36 months

Mean of P-wave amplitude

Comparison of electrical parameters measured using the 2 ECG methods: QRS amplitude

Time Frame: 36 months

Mean of QRS amplitude

Comparison of electrical parameters measured using the 2 ECG methods: QT/QTc

Time Frame: 36 months

Mean of QT/QTc (corrected QT) intervals

Comparison of electrical parameters measured using the 2 ECG methods: QRS duration

Time Frame: 36 months

Mean of QRS duration

Secondary Outcomes

  • Creation of bank of anormal ECG trace(36 months)
  • Validate the feasibility of recording an ECG trace with a connected watch for a child(36 months)
  • Compare the diagnostic capabilities of an ECG trace recorded with a watch against the reference method, the 12-lead ECG(36 months)
  • Validate the feasibility of recording and sending of ECG tracings with a connected watch at the patient's home(36 months)
  • Validate the sensibility of an ECG trace with a connected watch for a child(36 months)

Study Sites (1)

Loading locations...

Similar Trials